Please login to the form below

Not currently logged in
Email:
Password:

ICON boosts leadership teams

Dr Andrew Garrett, Dr Paul McCracken and Jim Carroll join

ICON Dr Andrew GarrettPharmaceutical service provider ICON has boosted its scientific operations, medical imaging and real world evidence leadership teams with three new senior appointments.

Dr Andrew Garrett (pictured right) joins ICON as executive vice president of scientific operations, with responsibility for the firm's global strategy and operational execution of its biostatistics and programming, pharmacovigilance, regulatory and medical affairs, medical writing, medical imaging and interactive technologies.

He has over 30 years of experience in pharmaceutical and contract research organisation (CRO) roles, joining from Quintiles where he led its global clinical analysis and reporting services group.

ICON Dr Paul McCrackenDr Paul McCracken (pictured left) has been appointed as vice president of medical imaging, bringing over 20 years of expertise in applying imaging and biomarkers to drug discovery and development across a range of therapeutic areas.

Most recently, Dr McCracken led the Imaging Centre of Excellence at Eisai, having previously worked at Merck Research Laboratories developing preclinical and translational imaging biomarkers and strategies to assess new molecular and biologic entities.

Also joining ICON's leadership team, Jim Carroll (pictured below right) becomes vice president of real world evidence (RWE), leading the company's RWE Center of Excellence in the development of market access solutions.

ICON Jim CarrollCarroll has over 20 years of CRO and pharmaceutical experience, and joins ICON from inVentiv Health where he led its real world data (RWD)-driven service unit. Previously, Carroll oversaw IMS Health's RWD analytic solutions offering, helping to improve decision outcomes throughout a product's lifecycle.

Dr Steve Cutler, ICON's chief operating officer, said: “I'm delighted to welcome Andrew, Paul and Jim to the ICON team.

“The bring a wealth of scientific operational and commercialisation expertise to ICON which will help us to advance our clients' products through their development pipelines and also drive their commercial success.”

20th October 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pulsar

THE SCIENCE BEHIND CREATIVE RESULTS When science meets art there's chemistry. We simply add passion, positivity and a human warmth....

Latest intelligence

Digital storytelling means building the story around data
The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
Pharma and free medicines: a different perspective
Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
arrow
The false economy of following the leader
How can companies in the sector shake things up?...

Infographics